BioSpace News Archive

Launch of a ground-breaking dry eye nutritional formula: Dr. Krawitz Dry Eye Support, completes a triad of Dr. Krawitz premium quality professional ocular supplements favored by doctors and patients.

This new brand, offering specialty personal insurance coverages tailored to the needs of their affluent client base, will implement Symbility’s complete suite of cloud-based tools.

The new stools feature 360° Dynamic Motion technology allowing freedom of movement that engages core muscles and helps to strengthen back muscles over time to reduce pain and fatigue.

Alexander Smith Appointed Executive Chairman

Acquisition expands suite of revenue integrity solutions for healthcare providers and adds market-leading capabilities in government reimbursement

The appointment will increase the size of the Board of Directors to nine members

The Company also announced today that it has initiated an innovative gene therapy program focused on applying novel gene therapy technology to discover and develop new therapies for ocular diseases

Financing led by Fidelity Management & Research Company, with Invus, Deerfield Management Company, Casdin Capital, Foresite Capital and Leerink Partners’ Affiliates

Virtual Twin technology will allow clinicians to predict the optimal drug dosing regimen for an individual patient – one that maximizes therapeutic benefit while minimizing side effects – by evaluating the impact of different drug doses, schedules, and combinations in the patient’s in silico ‘virtual twin’ first.

A new breakthrough delivery technology that optimizes the bioavailability and absorption of nutritional supplements, medical foods, and pharmaceutical drugs is now available to consumers and health-care practitioners.